Ramdas
Ramdas Chavakula, Secunderabad IN
Patent application number | Description | Published |
---|---|---|
20080234495 | Process for the Preparation of Almotriptan - The present invention encompasses a method for the preparation of Almotriptan and its pharmaceutically acceptable salts comprises, i) Methylation of 3-[5-(1-Pyrrolidinyl sulfonyl methyl) 1H-indol-yl]ethane amine ii) Treating crude Almotriptan with a hydroxy benzoic acid yields hydroxy benzoic acid addition salt of Almotriptan iii) Converting Almotriptan hydroxy benzoic acid addition salt to Almotriptan and iv) Salification of Almotriptan to its pharmaceutically acceptable salts | 09-25-2008 |
20090240064 | CRYSTALLINE FORM OF ATORVASTATIN HEMI-CALCIUM - The present invention relates to a new crystalline form of Atorvastatin hemi-calcium and also relates to a process for preparation of the same by treating Atorvastatin hemi-calcium amorphous form or form-I or mixture of amorphous and crystalline forms with methanol. | 09-24-2009 |
Ramdas Narayanappa, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20120262398 | MOBILE TERMINAL AND 3D IMAGE CONTROLLING METHOD THEREOF - Disclosed are a mobile terminal for controlling a 3D image using proximity touch, and a 3D image controlling method thereof. Aligning, moving and re-aligning a specific 3D object inside a 3D object group are performed, through proximity hovering. And, depth of the 3D object is automatically controlled by the various operations. This may provide various 3D-related interfaces to a user. | 10-18-2012 |
Ramdas Venkatram, Summit, NJ US
Patent application number | Description | Published |
---|---|---|
20090171031 | Method of Forming Polyalkene Substituted Carboxylic Acid Compositions - The residual chlorine content of a polyolefin-substituted carboxylic acylating agent formed by a halogen-assisted reaction of a polyalkene and at least one olefinic, monounsaturated mono- or dicarboxylic acid, anhydride or ester, is reduced when the reaction is conducted in the presence of a controlled amount of a metal compound. | 07-02-2009 |
Ramdas Vidya, Hinjewadi IN
Patent application number | Description | Published |
---|---|---|
20130252885 | FUSED TRICYCLIC COMPOUNDS AS ADENOSINE RECEPTOR ANTAGONIST - The present disclosure relates to fused tricyclic compounds of formula (I) or its tautomers, polymorphs, stereoisomers, prodrugs, solvate or a pharmaceutically acceptable salts, or pharmaceutical compositions containing them and methods of treating conditions and diseases that are mediated by thereof as A2A adenosine receptor antagonists. The compounds of the present disclosure are useful in the treatment, prevention or suppression of diseases and disorders that may be susceptible to improvement by the mediation of adenosine A2A receptor. Such conditions include, but are not limited to, Parkinsons disease, restless leg syndrome, Alzheimers disease, neurodegenerative disorder, inflammation, wound healing, dermal fibrosis, nocturnal myoclonus, cerebral ischaemia, myocardial ischemia, Huntington's disease, multiple system atrophy, corticobasal degeneration, Wilson's disease or other disorders of basal ganglia which results in dyskinesias, post traumatic stress disorder, hepatic cirrhosis, sepsis, spinal cord injury, retinopathy, hypertension, social memory impairment, depression, neuroprotection, narcolepsy or other sleep related disorders, attention deficit hyperactivity disorder, drug addiction, post traumatic stress disorder and vascular injury and the like. The present disclosure also relates to methods for the preparation of such compounds, and to pharmaceutical compositions containing them. | 09-26-2013 |